Predicting carriage with extended-spectrum beta-lactamase-producing bacteria at hospital admission: A cross-sectional study

Clinical Microbiology and Infection

Volumn 21, Issue 2, 2015, Pages 141-146

  Platteel, T N ^a,b   Leverstein van Hall, M A ^c   Cohen Stuart, J W ^d   Thijsen, S F T ^e   Mascini, E M ^f   van Hees, B C ^g   Scharringa, J ^b   Fluit, A C ^b   Bonten, M J M ^b  

^a Saltro   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c MEDICAL CENTER HAAGLANDEN   (Netherlands)

^d Medical Centre Alkmaar   (Netherlands)

^e DEPARTMENT OF SURGERY   (Netherlands)

^f RIJNSTATE HOSPITAL   (Netherlands)

^g GELRE HOSPITALS   (Netherlands)

Author keywords

Carriage; Enterobacteriaceae; ESBL; Hospital admission; Risk factors

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BACTERIA; BACTERIUM CARRIER; CONTROLLED STUDY; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING BACTERIA; FEMALE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NETHERLANDS; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; BACTERIAL INFECTIONS; BACTERIUM; CROSS-SECTIONAL STUDY; DECISION SUPPORT SYSTEM; DIAGNOSTIC TEST; ENZYMOLOGY; HETEROZYGOTE; HOSPITAL; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PERINEUM; PROCEDURES; SECRETION (PROCESS); VERY ELDERLY; YOUNG ADULT;

ENTEROBACTERIACEAE;

BETA LACTAMASE;

ADULT; AGED; AGED, 80 AND OVER; BACTERIA; BACTERIAL INFECTIONS; BACTERIOLOGICAL TECHNIQUES; BETA-LACTAMASES; CARRIER STATE; CROSS-SECTIONAL STUDIES; DECISION SUPPORT TECHNIQUES; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PATIENT ADMISSION; PERINEUM; PREVALENCE; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84923033812     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2014.09.014     Document Type: Article

References (22)

1. Pitout J.D. Infections with extended-spectrum beta-lactamase-producing Enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 2010, 70:313-333.
2. Oteo J., Perez-Vazquez M., Campos J. Extended-spectrum (beta)-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis 2010, 23:320-326.
3. Martinez J.A., Aguilar J., Almela M., Marco F., Soriano A., López F., et al. Prior use of carbapenems may be a significant risk factor for extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella spp. In patients with bacteraemia. JAntimicrob Chemother 2006, 58:1082-1085.
4. Heudorf U., Gustav C., Mischler D., Schulze J. Healthcare associated infections (HAI), antibiotic use and prevalence of multidrug-resistant bacteria (MDRO) in residents of long-term care facilities: the Frankfurt halt plus MDRO project 2012 [German]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2014, 57:414-422.
5. Hoogendoorn M., Smalbrugge M., Stobberingh E.E., van Rossum S.V., Vlaminckx B.J., Thijsen S.F., et al. Prevalence of antibiotic resistance of the commensal flora in Dutch nursing homes. JAm Med Dir Assoc 2013, 14:336-339.
6. Woerther P.L., Burdet C., Chachaty E., Andremont A. Trends in human fecal carriage of extended-spectrum beta-lactamases in the community: toward the globalization of CTX-M. Clin Microbiol Rev 2013, 26:744-758.
7. Geser N., Stephan R., Korczak B.M., Beutin L., Hächler H. Molecular identification of extended-spectrum-beta-lactamase genes from Enterobacteriaceae isolated from healthy human carriers in Switzerland. Antimicrob Agents Chemother 2012, 56:1609-1612.
8. Schoevaerdts D., Bogaerts P., Grimmelprez A., de Saint-Hubert M., Delaere B., Jamart J., et al. Clinical profiles of patients colonized or infected with extended-spectrum beta-lactamase producing Enterobacteriaceae isolates: a 20 month retrospective study at a Belgian university hospital. BMC Infect Dis 2011, 11:12.
9. Friedmann R., Raveh D., Zartzer E., Rudensky B., Broide E., Attias D., et al. Prospective evaluation of colonization with extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing enterobacteriaceae among patients during hospitalization. Infect Control Hosp Epidemiol 2009, 30:534-542.
10. Pasricha J., Koessler T., Harbarth S., Schrenzel J., Camus V., Cohen G., et al. Carriage of extended-spectrum beta-lactamase-producing Enterobacteriacae among internal medicine patients in Switzerland. Antimicrob Resist Infect Control 2013, 2:20.
11. Razazi K., Derde L.P., Verachten M., Legrand P., Lesprit P., Brun-Buisson C., et al. Clinical impact and risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria in the intensive care unit. Intensive Care Med 2012, 38:1769-1778.
12. Ben-Ami R., Schwaber M.J., Navon-Venezia S., Schwartz D., Giladi M., Chmelnitsky I., et al. Influx of extended-spectrum beta-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 2006, 42:925-934.
13. Voets G.M., Platteel T.N., Fluit A.C., Scharringa J., Schapendonk C.M., Stuart J.C., et al. Population distribution of beta-lactamase conferring resistance to third-generation cephalosporins in human clinical Enterobacteriaceae in the Netherlands. PLoS One 2012, 7:e52102.
14. Shitrit P., Reisfeld S., Paitan Y., Gottesman B.S., Katzir M., Paul M., et al. Extended-spectrum beta-lactamase-producing Enterobacteriaceae carriage upon hospital admission: Prevalence and risk factors. JHosp Infect 2013, 85:230-232.
15. Ruppe E., Pitsch A., Tubach F., de Lastours V., Chau F., Pasquet B., et al. Clinical predictive values of extended-spectrum beta-lactamase carriage in patients admitted to medical wards. Eur J Clin Microbiol Infect Dis 2012, 31:319-325.
16. Eikelenboom-Boskamp A., Cox-Claessens J.H., Boom-Poels P.G., Drabbe M.I., Koopmans R.T., Voss A. Three-year prevalence of healthcare-associated infections in Dutch nursing homes. JHosp Infect 2011, 78:59-62.
17. van Buul L.W., van der Steen J.T., Veenhuizen R.B., Achterberg W.P., Schellevis F.G., Essink R.T., et al. Antibiotic use and resistance in long term care facilities. JAm Med Dir Assoc 2012, 13:568. e1-13.
18. Tumbarello M., Trecarichi E.M., Bassetti M., De Rosa F.G., Spanu T., Di Meco E., et al. Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. Antimicrob Agents Chemother 2011, 55:3485-3490.
19. Derde L.P., Cooper B.S., Goossens H., Malhotra-Kumar S., Willems R.J., Gniadkowski M., et al. Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect Dis 2014, 14:31-39.
20. Bert F., Larroque B., Paugam-Burtz C., Dondero F., Durand F., Marcon E., et al. Pretransplant fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae and infection after liver transplant, France. Emerg Infect Dis 2012, 18:908-916.
21. Arnan M., Gudiol C., Calatayud L., Liñares J., Dominguez M.Á., Batlle M., et al. Risk factors for, and clinical relevance of, faecal extended-spectrum beta-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies. Eur J Clin Microbiol Infect Dis 2011, 30:355-360.
22. Platteel T.N., Stuart J.W., Voets G.M., Scharringa J., van de Sande N., Fluit A.C., et al. Evaluation of a commercial microarray as a confirmation test for the presence of extended-spectrum beta-lactamases in isolates from the routine clinical setting. Clin Microbiol Infect 2011, 17:1435-1438.